SPRY   $13.99  4.56% Market Closed After Close 13.64 -2.50%

ARS Pharmaceuticals Inc
Total Cash 218.74M
totalCashPerShare 2.256
EBITDA -56.67M
Total Debt 160.00K
quickRatio 32.608
currentRatio 32.823
Total Revenue 500.00K
debtToEquity 0.074
Revenue/Share 0.005
ROA -0.14753
ROE -0.19337
grossProfits
freeCashflow -26.33M
operatingCashflow -44.16M
earningsGrowth
revenueGrowth 49.0
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -30.68
profitMargins 0.0
enterpriseValue 1.21B
forwardPE -17.917646
floatShares 44.95M
sharesOutstanding 96.94M
sharesShort 11.92M
sharesShortPriorMonth 11.64M
dateShortInterest
sharesPercentSharesOut 0.12%
heldPercentInsiders 0.23%
heldPercentInstitutions 0.66%
Short Ratio help_outline 12.65%
shortPercentOfFloat 0.23%
impliedSharesOutstanding
bookValue 2.22
Price To Book help_outline 6.86
earningsQuarterlyGrowth
netIncomeToCommon -44.84M
trailingEps -0.47%
forwardEps -0.85%
enterpriseToEbitda -21.32
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.15 3Q 2024
institutionsCount 177
lastUpdated Nov. 1, 2024, 10:23 p.m.